HSF1 Activator Azadiradione Ameliorates Parkinson Disease and Extends Lifespan in Preclinical Models: Analysis of Underlying Molecular Mechanism
HOSSAINOOR RAHAMAN SARENG, Naibedya Dutta, Suvranil Ghosh, Upama Chowdhury, Vinod K. Nelson, Mohit Prasad, Subhash Chandra Mandal, Atin Kumar Mandal, Mahadeb Pal
This study shows that azadiradione enhances protein quality control mechanisms and alleviates Parkinson's disease symptoms in preclinical models.
bioRxiv · Apr 9, 2025 · PreprintMolecular Biology